AnaptysBio, Inc. (ANAB)
55.20
+0.14
(+0.25%)
USD |
NASDAQ |
Sep 18, 16:00
55.11
-0.09
(-0.16%)
After-Hours: 20:00
AnaptysBio Price : 55.20 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 55.76 | 55.77 | 53.71 | 55.20 | 868845.0 |
| Sep 17, 2026 | 55.09 | 55.79 | 54.49 | 55.06 | 439572.0 |
| Sep 16, 2026 | 54.44 | 54.80 | 53.62 | 54.31 | 394072.0 |
| Sep 15, 2026 | 54.28 | 55.32 | 53.22 | 54.68 | 351772.0 |
| Sep 14, 2026 | 54.58 | 55.70 | 54.00 | 54.11 | 436877.0 |
| Sep 11, 2026 | 55.43 | 56.32 | 53.75 | 53.87 | 336187.0 |
| Sep 10, 2026 | 55.43 | 56.43 | 54.31 | 55.16 | 300155.0 |
| Sep 09, 2026 | 55.59 | 57.89 | 55.25 | 55.70 | 295685.0 |
| Sep 08, 2026 | 55.48 | 58.16 | 54.79 | 56.60 | 1.036M |
| Sep 04, 2026 | 56.84 | 58.77 | 56.10 | 56.80 | 1.062M |
| Sep 03, 2026 | 56.33 | 57.77 | 55.00 | 57.46 | 366847.0 |
| Sep 02, 2026 | 56.13 | 57.90 | 54.66 | 55.84 | 421732.0 |
| Sep 01, 2026 | 56.82 | 58.09 | 54.84 | 55.28 | 773856.0 |
| Aug 31, 2026 | 55.83 | 57.22 | 55.00 | 57.03 | 332170.0 |
| Aug 28, 2026 | 57.24 | 57.24 | 55.38 | 56.28 | 358569.0 |
| Aug 27, 2026 | 58.03 | 58.43 | 57.10 | 57.29 | 533741.0 |
| Aug 26, 2026 | 58.27 | 58.86 | 57.36 | 58.00 | 210365.0 |
| Aug 25, 2026 | 58.09 | 58.99 | 56.80 | 58.37 | 341836.0 |
| Aug 24, 2026 | 56.96 | 59.06 | 55.56 | 58.44 | 627045.0 |
| Aug 21, 2026 | 57.23 | 58.78 | 56.62 | 57.74 | 318373.0 |
| Aug 20, 2026 | 58.52 | 59.69 | 56.33 | 56.69 | 389387.0 |
| Aug 19, 2026 | 60.31 | 60.31 | 58.43 | 59.26 | 258753.0 |
| Aug 18, 2026 | 58.90 | 60.02 | 58.16 | 58.99 | 260449.0 |
| Aug 17, 2026 | 57.78 | 59.88 | 57.48 | 59.69 | 255840.0 |
| Aug 14, 2026 | 56.00 | 58.54 | 55.30 | 58.47 | 330885.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| 4D Molecular Therapeutics, Inc. | 15.22 |
| Design Therapeutics, Inc. | 12.24 |
| Inhibrx Biosciences, Inc. | 109.35 |
| Agenus, Inc. | 7.85 |
| Amgen, Inc. | 385.65 |
Price Related Metrics
| PS Ratio | 6.999 |
| Price to Book Value | 125.71 |
| Price to Free Cash Flow | 368.90 |
| Earnings Yield | -1.96% |
| Market Cap | 1.603B |
| Operating PE Ratio | 39.87 |